Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Prof. Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, provide expert insights on key new data from ESMO 2021 presented for endometrial and ovarian cancers including:
START-Madrid, Early Phase Clinical Trials Unit
Hospital Fundación Jiménez Diaz
Professor of Department of Medical Oncology
Clinical Science Institute of the Léon Bérard Center
This program has been made available online.
Experts provide their thoughts on key data in breast, gynecologic, renal cell, urothelial, lung, hepatobiliary, and skin cancers presented at the 2022 ESMO Congress, from Clinical Care Options (CCO)
Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2022, from Clinical Care Options (CCO)
Expert commentary on new clinical trial data in cervical cancer and ovarian cancer, from Clinical Care Options (CCO)